Advait Gupta

5682 POSTS
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Exclusive articles:

EvaluAgent Secures $20 Million to Expand Call Center Agent Evaluation Software

EvaluAgent secures $20m to enhance its automated quality assurance testing software for contact centers. Their SmartScore system uses AI for identifying key moments and coaching tips, resulting in ongoing behavior change.

UK announces £21M fund to boost AI implementation in National Health Service

The UK gov is investing £21m to bring AI imaging and decision-support tools to NHS to improve diagnosis & treatment of heart conditions, cancer, and strokes, and to aid in early detection of lung cancer. NHS trusts can apply for funds for any appropriate AI diagnostic tool. #AIforNHS

EU Plants Flag in Silicon Valley Ahead of Tech Crackdown

EU's industry chief, Thierry Breton, visited Silicon Valley to prepare tech companies for new laws regarding social media, AI, and data. See Twitter's stress test results and how the DSA will affect Big Tech.

Singapore’s Grab lays off more than 1,100 workers in the wake of pandemic-caused economic downturn.

Grab, the ride-hailing and food delivery app in Southeast Asia, lays off 11% of its staff in response to changes in technology and competition. CEO aims for profitability.

Traditional Outsourcing Becoming Obsolete as AI Evolves

As AI revolutionizes outsourcing, will it completely replace digital services providers? Discover how AI is enhancing productivity, improving decisions, and shifting to higher-value services in this informative article.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img